Paediatric heart transplantation in Australia comes of age: 21 years of experience in a national centre

Internal Medicine Journal

Volumn 44, Issue 12, 2014, Pages 1223-1231

  Alexander, P M A ^a,b,c   Swager, A ^b   Lee, K J ^c,d   Shipp, A ^b   Konstantinov, I E ^b,c,d   Wilkinson, J L ^b,d   d'Udekem, Y ^b,c,d   Brizard, C ^b,c,d   Weintraub, R G ^b,c,d  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Heart transplantation; Paediatric

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN; EVEROLIMUS; IMMUNOSUPPRESSIVE AGENT; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ARTICLE; ASSISTED CIRCULATION; AUSTRALIA; BLOOD GROUP ABO INCOMPATIBILITY; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIAC GRAFT REJECTION; CHILD; CHILD DEVELOPMENT; CHILDHOOD MORTALITY; CONGENITAL HEART DISEASE; EXTRACORPOREAL OXYGENATION; GINGIVA HYPETROPHY; GLOMERULUS FILTRATION RATE; HEART TRANSPLANTATION; HIRSUTISM; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFANT; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MORBIDITY; PATIENT REFERRAL; PEDIATRIC HOSPITAL; PEDIATRIC SURGERY; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PULMONARY HYPERTENSION; QUALITY OF LIFE; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; VENTRICULAR ASSIST DEVICE; ADOLESCENT; CARDIOMYOPATHIES; EPIDEMIOLOGY; FEMALE; HEART DEFECTS, CONGENITAL; HEART FAILURE; MALE; MORTALITY; ORGANIZATION AND MANAGEMENT; PRESCHOOL CHILD; SURVIVAL; TRANSPLANTATION;

ADOLESCENT; AUSTRALIA; CARDIOMYOPATHIES; CHILD; CHILD, PRESCHOOL; FEMALE; HEART DEFECTS, CONGENITAL; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; INFANT; MALE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TISSUE AND ORGAN PROCUREMENT; WAITING LISTS;

EID: 84912079704     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12567     Document Type: Article

References (46)

1. Dipchand AI, Kirk R, Edwards LB, Kucheryavaya AY, Benden C, Christie JD etal. The registry of the international society for heart and lung transplantation: sixteenth official pediatric heart transplantation report - 2013. J Heart Lung Transplant 2013; 32: 979-988.
2. Kantor PF, Abraham JR, Dipchand AI, Benson LN, Redington AN. The impact of changing medical therapy on transplantation-free survival in pediatric dilated cardiomyopathy. J Am Coll Cardiol 2010; 55: 1377-1384.
3. Azakie T, Merklinger SL, McCrindle BW, Van Arsdell GS, Lee KJ, Benson LN etal. Evolving strategies and improving outcomes of the modified Norwood procedure: a 10-year single-institution experience. Ann Thorac Surg 2001; 72: 1349-1353.
4. d'Udekem Y, Cheung MM, Setyapranata S, Iyengar AJ, Kelly P, Buckland N etal. How good is a good Fontan? Quality of life and exercise capacity of Fontans without arrhythmias. Ann Thorac Surg 2009; 88: 1961-1969.
5. Dubin AM, Janousek J, Rhee E, Strieper MJ, Cecchin F, Law IH etal. Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study. J Am Coll Cardiol 2005; 46: 2277-2283.
6. Berul CI, Van Hare GF, Kertesz NJ, Dubin AM, Cecchin F, Collins KK etal. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol 2008; 51: 1685-1691.
7. Gajarski RJ, Mosca RS, Ohye RG, Bove EL, Crowley DC, Custer JR etal. Use of extracorporeal life support as a bridge to pediatric cardiac transplantation. J Heart Lung Transplant 2003; 22: 28-34.
8. Blume ED, Naftel DC, Bastardi HJ, Duncan BW, Kirklin JK, Webber SA. Outcomes of children bridged to heart transplantation with ventricular assist devices: a multi-institutional study. Circulation 2006; 113: 2313-2319.
9. Tsirka AE, Trinkaus K, Chen SC, Lipshultz SE, Towbin JA, Colan SD etal. Improved outcomes of pediatric dilated cardiomyopathy with utilization of heart transplantation. J Am Coll Cardiol 2004; 44: 391-397.
10. Registry AaNZOD. Anzod registry report 2012. Australia and New Zealand Organ Donation Registry. 2012.
11. Galati JC, Tibballs J, Carlin JB, Weintraub R, Carter BG. Probabilities of heart donors arising within specified times for child recipients. J Paediatr Child Health 2007; 43: 49-54.
12. West LJ, Pollock-Barziv SM, Dipchand AI, Lee KJ, Cardella CJ, Benson LN etal. ABO-incompatible heart transplantation in infants. N Engl J Med 2001; 344: 793-800.
13. Dipchand AI, Pollock BarZiv SM, Manlhiot C, West LJ, VanderVliet M, McCrindle BW. Equivalent outcomes for pediatric heart transplantation recipients: ABO-blood group incompatible versus ABO-compatible. Am J Transplant 2010; 10: 389-397.
14. Urschel S, Larsen IM, Kirk R, Flett J, Burch M, Shaw N etal. ABO-incompatible heart transplantation in early childhood: an international multicenter study of clinical experiences and limits. J Heart Lung Transplant 2013; 32: 285-292.
15. Bharucha T, Weintraub RG. The current status of paediatric cardiac transplantation. Asia-Pacific Cardiology 2008; 2: 5.
16. West LJ, Karamlou T, Dipchand AI, Pollock-BarZiv SM, Coles JG, McCrindle BW. Impact on outcomes after listing and transplantation, of a strategy to accept ABO blood group-incompatible donor hearts for neonates and infants. J Thorac Cardiovasc Surg 2006; 131: 455-461.
17. Iyengar AJ, Sharma VJ, Weintraub RG, Shipp A, Brizard CP, d'Udekem Y etal. Surgical strategies to facilitate heart transplantation in children after failed univentricular palliations: the role of advanced intraoperative surgical preparation. Eur J Cardiothorac Surg 2014; 46: 480-485.
18. Iyengar AJ, Sharma VJ, d'Udekem Y, Konstantinov IE. Aortic arch and pulmonary artery reconstruction during heart transplantation after failed Fontan procedure. Interact Cardiovasc Thorac Surg 2014; 18: 693-694.
19. Kirk R, Edwards LB, Kucheryavaya AY, Aurora P, Christie JD, Dobbels F etal. The registry of the international society for heart and lung transplantation: thirteenth official pediatric heart transplantation report - 2010. J Heart Lung Transplant 2010; 29: 1119-1128.
20. Rice JE, Shipp AT, Carlin JB, Vidmar SI, Weintraub RG. Late reduction in cyclosporine dosage does not improve renal function in pediatric heart transplant recipients. J Heart Lung Transplant 2002; 21: 1109-1112.
21. Ali A (2005). Health related quality of life following pediatric heart transplantation [Unpublished Master's thesis]. Melbourne, Australia: University of Melbourne.
22. Australian Bureau of Statistics. Australian demographic statistics September quarter 2012. 2013; 3101.1.
23. Ageing DoHa. An act to establish the Australian organ and tissue donation and transplantation authority, and for other purposes. 2008.
24. Roels L, Rahmel A. The European experience. Transpl Int 2011; 24: 350-367.
25. Authority OaT. Performance report 2012. 2012.
26. McDiarmid SV, Cherikh WS, Sweet SC. Preventable death: children on the transplant waiting list. Am J Transplant 2008; 8: 2491-2495.
27. Gilljam T, Higgins T, Bennhagen R, Wahlander H. First two decades of paediatric heart transplantation in Sweden - outcome of listing and post-transplant results. Acta Paediatr 2011; 100: 1442-1447.
28. Nield LE, McCrindle BW, Bohn DJ, West LJ, Coles JG, Freedom RM etal. Outcomes for children with cardiomyopathy awaiting transplantation. Cardiol Young 2000; 10: 358-366.
29. Mital S, Addonizio LJ, Lamour JM, Hsu DT. Outcome of children with end-stage congenital heart disease waiting for cardiac transplantation. J Heart Lung Transplant 2003; 22: 147-153.
30. Morrow WR, Naftel D, Chinnock R, Canter C, Boucek M, Zales V etal. Outcome of listing for heart transplantation in infants younger than six months: predictors of death and interval to transplantation. The pediatric heart transplantation study group. J Heart Lung Transplant 1997; 16: 1255-1266.
31. Almond CS, Thiagarajan RR, Piercey GE, Gauvreau K, Blume ED, Bastardi HJ etal. Waiting list mortality among children listed for heart transplantation in the United States. Circulation 2009; 119: 717-727.
32. Gilmore H, Millar KJ, Weintraub RG, Hislop J, Negri J, Brizard CP etal. Australian experience with VAD as a bridge to paediatric cardiac transplantation. Heart Lung Circ 2010; 19: 26-30.
33. Morrow WR, Frazier E, Naftel DC. Survival after listing for cardiac transplantation in children. Prog Pediatr Cardiol 2000; 11: 99-105.
34. Irving C, Parry G, Cassidy J, Hasan A, Griselli M, Kirk R. Outcomes following infant listing for cardiac transplantation: the impact of strategies introduced to counteract limited donor availability. Arch Dis Child 2010; 95: 883-887.
35. Mah D, Singh TP, Thiagarajan RR, Gauvreau K, Piercey GE, Blume ED etal. Incidence and risk factors for mortality in infants awaiting heart transplantation in the USA. J Heart Lung Transplant 2009; 28: 1292-1298.
36. Baldwin JT, Borovetz HS, Duncan BW, Gartner MJ, Jarvik RK, Weiss WJ etal. The national heart, lung, and blood institute pediatric circulatory support program. Circulation 2006; 113: 147-155.
37. Boucek MM, Mashburn C, Dunn SM, Frizell R, Edwards L, Pietra B etal. Pediatric heart transplantation after declaration of cardiocirculatory death. N Engl J Med 2008; 359: 709-714.
38. Bauer J, Thul J, Kramer U, Hagel KJ, Akinturk H, Valeske K etal. Heart transplantation in children and infants: short-term outcome and long-term follow-up. Pediatr Transpl 2001; 5: 457-462.
39. Groetzner J, Reichart B, Roemer U, Reichel S, Kozlik-Feldmann R, Tiete A etal. Cardiac transplantation in pediatric patients: fifteen-year experience of a single center. Ann Thorac Surg 2005; 79: 53-60.
40. Weiss ES, Meguid RA, Patel ND, Russell SD, Shah AS, Baumgartner WA etal. Increased mortality at low-volume orthotopic heart transplantation centers: should current standards change? Ann Thorac Surg 2008; 86: 1250-1259.
41. Kilic A, Weiss ES, Yuh DD, Shah AS, Cameron DE, Baumgartner WA etal. Institutional factors beyond procedural volume significantly impact center variability in outcomes after orthotopic heart transplantation. Ann Surg 2012; 256: 616-623.
42. Arnaoutakis GJ, George TJ, Allen JG, Russell SD, Shah AS, Conte JV etal. Institutional volume and the effect of recipient risk on short-term mortality after orthotopic heart transplant. J Thorac Cardiovasc Surg 2012; 143: 157-167.
43. Webber SA, Naftel DC, Fricker FJ, Olesnevich P, Blume ED, Addonizio L etal. Lymphoproliferative disorders after paediatric heart transplantation: a multi-institutional study. Lancet 2006; 367: 233-239.
44. Dayton JD, Richmond ME, Weintraub RG, Shipp AT, Orjuela M, Addonizio LJ. Role of immunosuppression regimen in post-transplant lymphoproliferative disorder in pediatric heart transplant patients. J Heart Lung Transplant 2011; 30: 420-425.
45. Abarbanell G, Mulla N, Chinnock R, Larsen R. Exercise assessment in infants after cardiac transplantation. J Heart Lung Transplant 2004; 23: 1334-1338.
46. Freier MC, Babikian T, Pivonka J, Burley Aaen T, Gardner JM, Baum M etal. A longitudinal perspective on neurodevelopmental outcome after infant cardiac transplantation. J Heart Lung Transplant 2004; 23: 857-864.